Nottingham, United Kingdom

Edward Cochrane

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Mind of Edward James Cochrane

Introduction

Edward James Cochrane, based in Nottingham, GB, is a notable inventor recognized for his contributions to the field of pharmaceuticals. With a single patent to his name, Cochrane has made significant strides in the development of compounds that could have a lasting impact on medical treatments.

Latest Patents

Cochrane's patent revolves around pharmaceutical compounds specifically focusing on benzodiazepine derivatives. This patent includes a complex formula detailing the components, such as R and R', where each can independently be hydrogen or a halogen. The patent further delineates configurations of T and Z along with various bonding conditions that are crucial for the functionality of these compounds. These derivatives are identified as inhibitors of respiratory syncytial virus (RSV), highlighting their potential use in treating or preventing RSV infections.

Career Highlights

Cochrane is affiliated with Pfizer Corporation, one of the leading companies in the pharmaceutical industry. His work at Pfizer has positioned him at the forefront of innovative drug development, particularly in areas relating to antiviral medications. Being a part of such a renowned organization has allowed him to effectively contribute to groundbreaking research and development.

Collaborations

Throughout his career, Edward James Cochrane has collaborated with various professionals, notably James Good, who has been an important coworker in the development of pharmaceutical innovations. This collaborative effort underscores the significance of teamwork in advancing research and achieving successful outcomes in the complex world of pharmaceuticals.

Conclusion

Edward James Cochrane's work exemplifies the spirit of innovation in the pharmaceutical sector. With his patent on benzodiazepine derivatives demonstrating significant potential against RSV, Cochrane's contributions may pave the way for new therapeutic strategies. His association with Pfizer Corporation further amplifies the importance of his inventions in addressing pressing health challenges. As he continues to collaborate and innovate, the medical field eagerly anticipates the future developments he may bring.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…